Hepion Pharmaceuticals Quote - HEPA

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.1601

Bid

0.16

Offer

0.1625

Volume

14,703

0.00 Day's Range 0.00

0.121 52 Week Range 3.33

Market Cap

1.114M

Previous Close

0.1631

Open

Last Trade

1000

0.1601

(formt)

Last Trade Time

20:50:03

Financial Volume

VWAP

Average Volume (3m)

12,156,346

Shares Outstanding

6,958,371

Dividend Yield

PE Ratio

-0.02

Earnings Per Share (EPS)

-7.03

Revenue

Net Profit

-48.93M

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hepion.com

Headquarters

Wilmington, Delaware, USA

Founded

Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0.16. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0.121 to US$ 3.33.

Hepion Pharmaceuticals currently has 6,958,371 shares in issue. The market capitalisation of Hepion Pharmaceuticals is US$1.13 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.02.

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 8-K - Current report

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0159	-9.03409090909	0.176	0.1942	0.1575	6421275	0.17859963	CS
4	-0.0564	-26.0508083141	0.2165	0.28	0.149	29040309	0.20685633	CS
12	-0.4699	-74.5873015873	0.63	0.7345	0.121	12156346	0.20161755	CS
26	-0.5909	-78.6817576565	0.751	0.89	0.121	5358558	0.20367349	CS
52	-2.2599	-93.3842975207	2.42	3.33	0.121	2697639	0.22015211	CS
156	-19.4399	-99.1831632653	19.6	26.6	0.121	1067350	2.45909307	CS
260	-92.8399	-99.8278494624	93	123.6	0.121	1392647	24.78704044	CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?

The current share price of Hepion Pharmaceuticals is US$ 0.1601

How many Hepion Pharmaceuticals shares are in issue?

Hepion Pharmaceuticals has 6,958,371 shares in issue

What is the market cap of Hepion Pharmaceuticals?

The market capitalisation of Hepion Pharmaceuticals is USD 1.13M

What is the 1 year trading range for Hepion Pharmaceuticals share price?

Hepion Pharmaceuticals has traded in the range of US$ 0.121 to US$ 3.33 during the past year

What is the PE ratio of Hepion Pharmaceuticals?

The price to earnings ratio of Hepion Pharmaceuticals is -0.02

What is the reporting currency for Hepion Pharmaceuticals?

Hepion Pharmaceuticals reports financial results in USD

What is the latest annual profit for Hepion Pharmaceuticals?

The latest annual profit of Hepion Pharmaceuticals is USD -48.93M

What is the registered address of Hepion Pharmaceuticals?

The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Hepion Pharmaceuticals website address?

The website address for Hepion Pharmaceuticals is www.hepion.com

Which industry sector does Hepion Pharmaceuticals operate in?

Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
BREABrera Holdings PLC	US$ 1.53 (142.36%)	17.31M
FMTOFemto Technologies Inc	US$ 7.31 (104.38%)	2.28M
WAFUWah Fu Education Group Ltd	US$ 3.30 (84.36%)	7.7M
MFImF International Ltd	US$ 0.9763 (62.80%)	7.39M
MBRXMoleculin Biotech Inc	US$ 1.71 (59.81%)	7.22M
TLFTandy Leather Factory Inc	US$ 2.00 (-46.81%)	200
GELSGelteq Ltd	US$ 1.00 (-42.20%)	851
KTCCKeyTronic Corporation	US$ 2.00 (-35.48%)	101
CFSBCFSB Bancorp Inc	US$ 5.01 (-34.60%)	71
YYAIConnexa Sports Technologies Inc	US$ 0.8307 (-34.59%)	461.64k
BREABrera Holdings PLC	US$ 1.52 (140.77%)	17.34M
WAFUWah Fu Education Group Ltd	US$ 3.31 (84.92%)	7.7M
MFImF International Ltd	US$ 0.9761 (62.76%)	7.39M
MBRXMoleculin Biotech Inc	US$ 1.71 (59.81%)	7.22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 17.33 (0.00%)	2.47M

Symbol

Price

Vol.